BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 27351666)

  • 1. Underlying renal insufficiency: the pivotal risk factor for Pneumocystis jirovecii pneumonia in immunosuppressed patients with non-transplant glomerular disease.
    Ye WL; Tang N; Wen YB; Li H; Li MX; Du B; Li XM
    Int Urol Nephrol; 2016 Nov; 48(11):1863-1871. PubMed ID: 27351666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: A case-control study.
    Park SY; Jung JH; Kwon H; Shin S; Kim YH; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH; Han DJ
    Transpl Infect Dis; 2020 Apr; 22(2):e13245. PubMed ID: 31943590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis jirovecii pneumonia in renal transplant recipients: a national center experience.
    Borstnar S; Lindic J; Tomazic J; Kandus A; Pikelj A; Prah J; Skvarc M; Godnov U; Kovac D
    Transplant Proc; 2013 May; 45(4):1614-7. PubMed ID: 23726632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for Pneumocystis jirovecii pneumonia in kidney transplant recipients and appraisal of strategies for selective use of chemoprophylaxis.
    de Boer MG; Kroon FP; le Cessie S; de Fijter JW; van Dissel JT
    Transpl Infect Dis; 2011 Dec; 13(6):559-69. PubMed ID: 21689251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.
    Kitazawa T; Seo K; Yoshino Y; Asako K; Kikuchi H; Kono H; Ota Y
    J Infect Chemother; 2019 May; 25(5):351-354. PubMed ID: 30711257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary co-infections by Pneumocystis jirovecii and Aspergillus fumigatus in non-HIV patients: A report of two cases and literature review.
    Markantonatou AM; Ioakimidou A; Arvaniti K; Manou E; Papadopoulos V; Kiriklidou P; Samaras K; Kioumi A; Vyzantiadis TA
    Mycoses; 2017 Oct; 60(10):626-633. PubMed ID: 28660636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of prophylaxis for Pneumocystis jirovecii pneumonia involving trimethoprim-sulfamethoxazole dose reduction in kidney transplantation.
    Prasad GVR; Beckley J; Mathur M; Gunasekaran M; Nash MM; Rapi L; Huang M; Zaltzman JS
    BMC Infect Dis; 2019 Apr; 19(1):311. PubMed ID: 30953458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tolerability of low-dose sulfamethoxazole/trimethoprim for Pneumocystis jirovecii pneumonia prophylaxis in kidney transplant recipients.
    Zmarlicka M; Martin ST; Cardwell SM; Nailor MD
    Prog Transplant; 2015 Sep; 25(3):210-6. PubMed ID: 26308779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Insufficiency in Concert with Renin-angiotensin-aldosterone Inhibition Is a Major Risk Factor for Hyperkalemia Associated with Low-dose Trimethoprim-sulfamethoxazole in Adults.
    Higashioka K; Niiro H; Yoshida K; Oryoji K; Kamada K; Mizuki S; Yokota E
    Intern Med; 2016; 55(5):467-71. PubMed ID: 26935365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predisposing factors, clinical characteristics and outcome of Pneumonocystis jirovecii pneumonia in HIV-negative patients.
    Kofteridis DP; Valachis A; Velegraki M; Antoniou M; Christofaki M; Vrentzos GE; Andrianaki AM; Samonis G
    J Infect Chemother; 2014 Jul; 20(7):412-6. PubMed ID: 24767467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pneumocystis pneumonia in a renal transplant recipient].
    Özkoç S; İnceboz T; Sıfıl A; Tuncay S; Akisü Ç
    Turkiye Parazitol Derg; 2010; 34(4):186-9. PubMed ID: 21391190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Septrin psychosis' among renal transplant patients with Pneumocystis jirovecii pneumonia.
    Walker LE; Thomas S; McBride C; Howse M; Turtle LC; Vivancos R; Beeching NJ; Beadsworth MB
    J Antimicrob Chemother; 2011 May; 66(5):1117-9. PubMed ID: 21393210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Four-Center Retrospective Study of the Efficacy and Toxicity of Low-Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Pneumonia in Patients without HIV Infection.
    Kosaka M; Ushiki A; Ikuyama Y; Hirai K; Matsuo A; Hachiya T; Hanaoka M
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pneumocystis pneumonia in solid organ transplant recipients: not yet an infection of the past.
    Wang EH; Partovi N; Levy RD; Shapiro RJ; Yoshida EM; Greanya ED
    Transpl Infect Dis; 2012 Oct; 14(5):519-25. PubMed ID: 22571389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of Pneumocystis jirovecii pneumonia and colonization in iatrogenically immunosuppressed and immunocompetent patients].
    Özkoç S; Bayram Delibaş S
    Mikrobiyol Bul; 2015 Apr; 49(2):221-30. PubMed ID: 26167822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with idiopathic membranous nephropathy.
    Yang L; Xia P; Zhou Y; Cui Q; Chen G; Zheng K; Qin Y; Li X
    Eur J Clin Microbiol Infect Dis; 2021 Nov; 40(11):2305-2314. PubMed ID: 34047874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: a case report and literature review.
    Li H; Huang H; He H
    BMC Pulm Med; 2016 Nov; 16(1):144. PubMed ID: 27835947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High daily doses of trimethoprim/sulfamethoxazole are an independent risk factor for adverse reactions in patients with pneumocystis pneumonia and AIDS.
    Chang HM; Tsai HC; Lee SS; Kunin C; Lin PC; Wann SR; Chen YS
    J Chin Med Assoc; 2016 Jun; 79(6):314-9. PubMed ID: 27025225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association between Cytomegalovirus co-infection with Pneumocystis pneumonia and mortality in immunocompromised non-HIV patients.
    Korkmaz Ekren P; Töreyin ZN; Nahid P; Doskaya M; Caner A; Turgay N; Zeytinoglu A; Toz S; Bacakoglu F; Guruz Y; Erensoy S
    Clin Respir J; 2018 Nov; 12(11):2590-2597. PubMed ID: 30244544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.